{{Rsnum
|rsid = 4149313
|geno1 = (A;A)
|geno2 = (A;G)
|geno3 = (G;G)
|Status = Merged
|Merged = 2066714
|Gene = ABCA1
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|Chromosome=9
|position=104824472
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 73.5 | 26.5 | 0.0
| HCB | 5.8 | 39.4 | 54.7
| JPT | 21.4 | 44.6 | 33.9
| YRI | 19.7 | 52.4 | 27.9
| ASW | 26.3 | 52.6 | 21.1
| CHB | 5.8 | 39.4 | 54.7
| CHD | 9.2 | 39.4 | 51.4
| GIH | 74.0 | 22.0 | 4.0
| LWK | 20.0 | 54.5 | 25.5
| MEX | 56.1 | 33.3 | 10.5
| MKK | 32.7 | 51.9 | 15.4
| TSI | 70.6 | 27.5 | 2.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=4149313
|allele=C
|frequency=0.133
|uid=1103652149294
|type=heterozygous_SNP
|hugo=ABCA1
|ensembl gene=ENSG00000165029
|ensembl transcript=ENST00000297693
|sift=TOLERATED
|disease=Defects in ABCA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) (MIM:604091); also known as familial hypoalphalipoproteinemia (FHA). HDLD2 is inherited as autosomal dominant trait. It is characterized by moderately low HDL cholesterol, predilection toward premature coronary artery disease (CAD) and a reduction in cellular cholesterol efflux.
}}

{{PMID Auto
|PMID=22668585
|Title=Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses
|OA=1
}}

{{PMID Auto
|PMID=23111454
|Title=Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease
}}

{{PMID Auto
|PMID=23262498
|Title=Impact of geneticfactorsondyslipidemia in HIV-infected patients starting antiretroviral therapy
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}